Navigation Links
InspireMD Announces Enrollment of First Patients in the MGuard(TM) Acute Myocardial Infarction Clinical Trial Data Will be Used to Confirm Initial Positive Results
Date:9/23/2008

TEL AVIV, Israel, September 23 /PRNewswire/ -- InspireMD, Ltd. announced today the enrollment of the first 3 patients in its study of MGuard(TM) coronary stent in acute myocardial infarction. The GUARD Study (MGuard(TM) in Acute Myocardial Infarction Study) is designed to evaluate the safety and efficacy of MGuard(TM) in patients suffering from ST-segment elevation myocardial infarction. The first 3 patients were implanted successfully with the MGuard(TM) Coronary Stent, in the Jagiellonian University Clinic, in Krakow, Poland.

"It is very exciting for me to see this study take off and confirm our expectations," said Dr. Dariusz Dudek, the GUARD Study Chief Investigator, from Jagiellonian University in Krakow, "The MGuard(TM) represents a very innovative approach to the management of thrombus and embolization, which adversely affect the prognosis and survival rate of a large proportion of Acute MI patients. From the cases of acute MI where MGuard(TM) was implanted so far in various countries, we learned that the results were very successful and that the product has a strong efficacy and safety profile with an exceptional deliverability. I look forward to confirm these initial findings through this study."

"The successful clinical development of MGuard(TM) will benefit Acute MI patients throughout the world," said Eli Bar, CTO and VP R&D of InspireMD, "MGuard(TM) is designed to provide a comprehensive solution to the embolization threat, during and post procedure. We are confident that the GUARD Study will confirm what we have experienced so far in cath labs around the world that the product performs well and delivers extra safety to acute MI patients."

The GUARD Study is a prospective, multi center study, designed to confirm the feasibility, efficacy and safety of MGuard(TM) in acute MI patients. The GUARDS study will include 60 patients, and its primary endpoints are complete resolution of ST-segment elevation and restoration of flow thr
'/>"/>

SOURCE InspireMD, Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Affitech Announces Second Milestone in Roche Antibody Discovery Collaboration
2. BioMS Medical announces receipt of milestone payment from Eli Lilly and Company
3. Emisphere Announces Recruitment Phase III Study for Oral Osteoarthritis Treatment
4. China-Biotics, Inc. Announces Results of 2008 Annual General Meeting of Shareholders
5. BioElectronics Corp. Announces $400,000 in New Orders From the Middle East
6. The Michigan Life Sciences Pipeline Announces New Best Practices Seminars Tailored to Michigan Businesses
7. Enigma Diagnostics Announces an Award of GBP 1.8 Million From UK Government
8. Oncothyreon announces receipt of NASDAQ letter regarding compliance with NASDAQ Global Market listing standards
9. Quark Pharmaceuticals Announces Poster Presentations at RNAi Europe 2008
10. Dendreon Announces Webcast Presentation at UBS Global Life Sciences Conference
11. Tethys Bioscience Announces Acquisition of Lipomics Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... 2015 e2b teknologies , a ... in Northeast Ohio, today announced a leading independent multi-specialty ... its upgrade to the latest version of Sage ... practice of its kind in the region, the organization ... transactions, so efficiency and data accessibility are paramount to ...
(Date:3/5/2015)... Southlake, Texas (PRWEB) March 05, 2015 ... treatment of acute and chronic orthopedic conditions such ... runner’s knee, tennis elbow, and joint pain due ... also be administered during orthopedic surgeries to promote ... patented scientific advances in nearly pain-free bone marrow ...
(Date:3/4/2015)... , March 4, 2015 In an ... the UPMC Center for Health Security review the clinical ... can be used as bioweapons. The article, "Clinical Management ... today on the website of the New England ... Adalja, Eric Toner , and Tom Inglesby—review the ...
(Date:3/4/2015)... , March 4, 2015  Brooklyn residents now ... acute and chronic pain and injuries. Nunzio Saulle ... the grand opening of his NJS Physical Medicine and ... on Thursday, March 5, 2015. Health Plus Management, ... which is located at 1178 Flatbush Avenue. This new ...
Breaking Biology Technology:Physician Group Practice Chooses e2b teknologies to Support Its Upgrade to Sage 100 ERP 2014 2Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 2Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 3Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 4Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 5Latest Clinical Information On Bioterrorism Threats 2NJS Physical Medicine & Rehabilitation Opening on Flatbush Avenue, Brooklyn, NY 2
... 11 Schering-Plough,Corporation (NYSE: SGP ) today announced ... of a New Drug Application (NDA) for ZEGERID(R),(omeprazole/sodium bicarbonate) ... a branded over-the-counter (OTC) product to treat frequent,heartburn., ... license agreement with,Santarus, Inc. of San Diego, Calif., which ...
... analysis affordable and accessible to all researchers, ... today that Harvard Medical School and the University ... Program. Each University,purchased access to whole genome human ... Consortium and distributed by Open Biosystems., (Logo: ...
... China,Bionanometer Industries Corporation (Pink Sheets: CBIU), a ... signed an agreement to,establish long-term strategic cooperative ... Guangzhou LGLY Advertising LTD is China,s top ... and is well-known for its core senior ...
Cached Biology Technology:Schering-Plough Announces Filing of U.S. Application for OTC ZEGERID(R) 2Schering-Plough Announces Filing of U.S. Application for OTC ZEGERID(R) 3Open Biosystems' Open Access RNAi Program Adopted by Harvard Medical School and University of North Carolina 2CBIU Signs Agreement with LGLY Advertising LTD 2
(Date:2/24/2015)... This report analyzes the worldwide markets for Iris ... for the US, Canada , ... Asia-Pacific , Middle East , and ... are provided for the period 2013 through 2020. Also, a ... and analytics are derived from primary and secondary research. Company ...
(Date:2/19/2015)... , Feb .19, 2015 Research and Markets ... addition of the "Military Electro-Optical / Infrared ... Technology, by Platform - Forecast to 2020" ... military electro-optical/infrared systems market is expected to reach ... of 7.71%. This report segments the ...
(Date:2/12/2015)... , Feb. 12, 2015 NXT-ID, Inc. (NASDAQ: ... "Company"), a biometric authentication company focused on the growing ... provisional patent 62/113114 for DISTRIBUTED METHOD AND ... The patent further establishes NXT-ID,s position in the ... property portfolio the ability for multiple devices to collaborate ...
Breaking Biology News(10 mins):World Iris Biometrics Industry 2World Iris Biometrics Industry 3World Iris Biometrics Industry 4World Iris Biometrics Industry 5World Iris Biometrics Industry 6World Iris Biometrics Industry 7World Iris Biometrics Industry 8World Iris Biometrics Industry 9World Iris Biometrics Industry 10World Iris Biometrics Industry 11Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 2Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 3NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3
... declined significantly as temperatures have rapidly warmed on the ... the National Science Foundation (NSF). The study indicates ... tourism, have had the greatest effect on the chinstrap ... and conservation organization, Oceanites, Inc., of Chevy Chase, Md., ...
... - an antibacterial chemical found in toothpaste and other ... allergy development in children. This comes from the Norwegian ... Institute of Public Health is involved. Similar results are ... in use for decades, but was recently associated with ...
... or jerks its head uncontrollably for no apparent reason. ... in people, most notably trigeminal neuralgia, and headshaking in ... diagnosing and treating the condition in horses, the pathology ... needed. A recent study led by ...
Cached Biology News:Changing climate, not tourism, seems to be driving decline in chinstrap-penguin populations 2Changing climate, not tourism, seems to be driving decline in chinstrap-penguin populations 3Triclosan in cosmetics and personal care products can increase allergy risk 2Study investigates headshaking in horses 2
Quantibody Human Angiogenesis Array 1 (1 slide) Class: Quantitative Antibody Arrays Product Group: Antibody Array...
BD IMagnet 1 each...
Hucal Agx Antigen Expression Service Specificity: Hucal Agx ...
... Casein Kinase 1, active MW: ... 150mM NaCl, 0.02% Brij-35, 1mM dithiothreitiol ... Activity data, refer to the Certificate ... enzyme. Purification: ammonium salt precipitation followed ...
Biology Products: